Northwire Canada EditionTuesday, July 28, 2026
Northwire
LUG 81.27 +2.4% ETG 2.65 +1.1% ARIC 0.860 +2.4% ABC 0.020 +0.0% WEC 0.010 +0.0% NTB 0.020 +0.0% URC 3.83 −8.2% BEX 0.085 +6.2% SUM 1.32 +0.0% FMN 0.270 +10.2% PHNM 0.405 +12.5% HDRO 1.11 −6.7% PWM 0.620 −1.6% LIO 0.155 +10.7% NTH 0.160 +1.6% ELEF 0.120 −4.0% LUG 81.27 +2.4% ETG 2.65 +1.1% ARIC 0.860 +2.4% ABC 0.020 +0.0% WEC 0.010 +0.0% NTB 0.020 +0.0% URC 3.83 −8.2% BEX 0.085 +6.2% SUM 1.32 +0.0% FMN 0.270 +10.2% PHNM 0.405 +12.5% HDRO 1.11 −6.7% PWM 0.620 −1.6% LIO 0.155 +10.7% NTH 0.160 +1.6% ELEF 0.120 −4.0%
Financings

Gstaad signs Claranova merger deal, closes $3.5M raise

GTD · Price

Executive Summary

  • Gstaad Capital Corp. has entered into a definitive amalgamation agreement with Claranova Technologies Inc. to form a new entity named Illumisoft Corp., which will carry on the business of Claranova.
  • The transaction involves a consolidation of Gstaad securities (0.2 post-consolidation share for each pre-consolidation share) and an exchange of shares for shares in the resulting issuer.
  • Concurrent with the amalgamation, Gstaad is closing the first tranche of a private placement, raising $3.5M, with a total target raise of $7M.

Key Details

  • Transaction Structure: Amalgamation of Gstaad Capital Corp. and Claranova Technologies Inc. under the BCBCA to form Illumisoft Corp.
  • Share Exchange Ratio: Each post-consolidation Gstaad share exchanges for one resulting issuer share. Each Claranova share exchanges for one resulting issuer share.
  • Deemed Transaction Price: 35 cents per resulting issuer share (based on Gstaad's last trading price on a post-consolidation basis).
  • Consideration Value: The value of consideration for the acquisition of Claranova shares is $7,791,631.75.
  • Post-Transaction Ownership (Estimated):
    • Gstaad Shareholders: ~3.96%
    • Claranova Shareholders: ~46.89%
    • Concurrent Financing Subscribers: ~49.15%
  • Concurrent Financing (First Tranche):
    • Closed: Yes.
    • Instrument: Subscription receipts.
    • Price: 30 cents per subscription receipt.
    • Quantity: 11,723,251 subscription receipts.
    • Gross Proceeds: $3,516,975.30.
  • Concurrent Financing (Total Target):
    • Total Gross Proceeds Target: Up to $7,000,000.20.
    • Total Subscription Receipts Target: Up to 23,333,334.
  • Finder Warrants:
    • Issued: 425,390 non-transferable share purchase warrants.
    • Exercise Price: 30 cents per share.
    • Term: Two years from closing.
    • Cash Fees Paid: $127,617.02.
  • Use of Proceeds: Finance business activities of the resulting issuer and general working capital.
  • Escrow: Proceeds placed in escrow; released upon satisfaction of conditions precedent (regulatory approvals, shareholder approvals, completion of transaction).
  • Refund Condition: If conditions are not met by Feb 28, 2026, or transaction terminates, subscription price plus pro-rata interest is refunded.
  • Statutory Hold: 4 months and 1 day from issuance.
  • Related Party Disclosure: Ehsan Agahi is a director of both Gstaad and Claranova (non-arm's-length).
  • Proposed Management (Illumisoft Corp.):
    • Chairman: Ehsan Agahi
    • CEO: Brett Nicholds
    • CFO: Ali Pickett
    • CTO: Michael Johnson
    • Corporate Secretary: David W. Smalley
    • Directors: Ryan Adam, Cameron Groome
  • Target Business (Claranova/Illumisoft): Advanced design, manufacturing, and deployment of energy-efficient lighting systems. Proprietary Health Canada-approved upper-room germicidal ultraviolet (GUV) disinfection technology.
  • Historical Revenue (Illumisoft): $1.0 million to $1.4 million annually over the past four years.
  • Loan: Gstaad provided an unsecured, interest-free loan of $25,000 to Claranova.

Notable Quotes

  • None explicitly quoted in the text, though the release details the strategic intent to create a Tier 2 Technology issuer on the TSX Venture Exchange.
Read the original news release →

More from Gstaad Capital Corp